211 related articles for article (PubMed ID: 16259944)
1. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.
Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944
[TBL] [Abstract][Full Text] [Related]
2. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
[TBL] [Abstract][Full Text] [Related]
3. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells.
Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ
Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829
[TBL] [Abstract][Full Text] [Related]
4. The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Dev Neurobiol; 2012 Jun; 72(6):821-42. PubMed ID: 22076965
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of p57kip² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.
Chow SE; Wang JS; Lin MR; Lee CL
J Cell Biochem; 2011 Nov; 112(11):3459-68. PubMed ID: 21769918
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated overexpression of a cyclin-dependent kinase inhibitor, p57Kip2, suppressed vascular smooth muscle cell proliferation.
Takagi Y
Hokkaido Igaku Zasshi; 2002 May; 77(3):221-30. PubMed ID: 12056049
[TBL] [Abstract][Full Text] [Related]
7. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
Figliola R; Busanello A; Vaccarello G; Maione R
J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
[TBL] [Abstract][Full Text] [Related]
8. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
[TBL] [Abstract][Full Text] [Related]
9. p57KIP2: "Kip"ing the cell under control.
Pateras IS; Apostolopoulou K; Niforou K; Kotsinas A; Gorgoulis VG
Mol Cancer Res; 2009 Dec; 7(12):1902-19. PubMed ID: 19934273
[TBL] [Abstract][Full Text] [Related]
10. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
Xu D; Wang M; Liu Y
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
[TBL] [Abstract][Full Text] [Related]
11. RNA interference targeting ORC1 gene suppresses the proliferation of vascular smooth muscle cells in rats.
Shu MQ; Qin YL; Jiang MH
Exp Mol Pathol; 2008 Jun; 84(3):206-12. PubMed ID: 18499104
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
[TBL] [Abstract][Full Text] [Related]
13. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
Vlachos P; Joseph B
Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation.
Chiang CT; Chu WK; Chow SE; Chen JK
J Cell Physiol; 2009 Apr; 219(1):117-22. PubMed ID: 19089994
[TBL] [Abstract][Full Text] [Related]
15. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
Tury A; Mairet-Coello G; DiCicco-Bloom E
Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
[TBL] [Abstract][Full Text] [Related]
16. Double blockade of cell cycle progression by coptisine in vascular smooth muscle cells.
Tanabe H; Suzuki H; Mizukami H; Inoue M
Biochem Pharmacol; 2005 Oct; 70(8):1176-84. PubMed ID: 16140275
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative action of cudraflavone B, isolated from Cudrania tricuspidata, through the downregulation of pRb phosphorylation in aortic smooth muscle cell proliferation signaling.
Kim TJ; Han HJ; Lim Y; Song MC; Kim J; Hong JT; Yoo HS; Pyo MY; Hwang BY; Lee MK; Yun YP
J Cardiovasc Pharmacol; 2009 Apr; 53(4):341-8. PubMed ID: 19295442
[TBL] [Abstract][Full Text] [Related]
18. p57Kip2 is expressed in quiescent mouse bone marrow side population cells.
Umemoto T; Yamato M; Nishida K; Yang J; Tano Y; Okano T
Biochem Biophys Res Commun; 2005 Nov; 337(1):14-21. PubMed ID: 16176803
[TBL] [Abstract][Full Text] [Related]
19. BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes.
Gosselet FP; Magnaldo T; Culerrier RM; Sarasin A; Ehrhart JC
Cell Signal; 2007 Apr; 19(4):731-9. PubMed ID: 17112701
[TBL] [Abstract][Full Text] [Related]
20. Cyclic changes in the expression of p57(kip2) in human endometrium and its regulation by steroid hormones in endometrial stromal cells in vitro.
Kim ST; Lee SK; Gye MC
Reprod Sci; 2012 Jan; 19(1):92-101. PubMed ID: 22064387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
